Study finds Ozempic, Wegovy ingredient shows promise for alcohol use disorder in people with obesity

Novo obesity shot Wegovy helped alcoholics drink less in study

By Naomi Kresge, Bloomberg News Novo Nordisk A/S’s obesity shot Wegovy helped people with alcoholism reduce their drinking, in the first controlled study of patients who sought help with their addiction. Volunteers on Wegovy reported drinking heavily for five days in a 30-day period after six months of treatment, 12 fewer days than before they started. The improvement showed in other measures of addiction, such as total alcohol consumption and b…

Semaglutide reduces heavy drinking for adults with alcohol use disorder, obesity

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, according to findings from a randomized controlled trial published in The Lancet.

Weight-loss drug semaglutide has a surprising benefit: It may help people drink less, says Lancet study

Patients with obesity and alcohol dependence, who received weekly semaglutide injections, reported fewer heavy-drinking days.

Weight loss jabs 'could help reduce alcohol intake'

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol cravings, researchers have found.